The case of a 42-year-old woman with prolonged migraine visual aura without headache, whose long-lasting episodes of visual aura were successfully controlled by oral sumatriptan, is reported. Effectiveness of sumatriptan was unequivocal, since, after taking sumatriptan, duration of aura would drop from 1.5 h to approximately 20 min. This case suggests that sumatriptan may cross the blood-brain barrier and block spreading depression.
KaubeHHoskinKLGoadsbyPJ.Sumatriptan inhibits central trigeminal neurons only after blood-brain barrier disruption.
Br J Pharmacol1993;
107:
788–92.
2.
BatesDAshfordEDawsonREnsinkFBGilhusNEOlesenJSubcutaneous sumatriptan during migraine aura.
Neurology1994;
44:
1587–92.
3.
ShepheardSIWilliamsonDJWilliamsJHillRGHargreavesRJ.Comparison of the effects of sumatriptan and the NK1 antagonist CP-99,994 on plasma extravasation in the dura mater and c-fos mRNA expression in the trigeminal nucleus caudalis of rats.
Neuropharmacology1995;
34:
255–61.
4.
Headache Classification Committee of the International Headache Society.
Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain.
Cephalalgia1988;
8Suppl 7:
1–96.
5.
MortimerMJGoodRA.The VEP in acephalgic migraine.
Headache1990;
30:
285–8.
6.
PiperRDMathesonJMHellierMVonauMLambertGAOlaussonBCortical spreading depression is not seen intraoperatively during temporal lobectomy in humans.
Cephalalgia1991;
11:
S1–2.
7.
McLachlanRSGirvinJP.Spreading depression of Leo in rodent and human cortex.
Brain Res1994;
66:
133–6.
8.
MayevskyADoronAManorTMeilinSZarchinNOuaknineGE.Cortical spreading depression recorded from the human brain using a multiparametric monitoring system.
Brain Res1996;
740:
268–74.
9.
BanerjeeMFindleyLJ.Sumatriptan in the treatment of acute migraine with aura.
Cephalalgia1992;
12:
39–44.
MayAShepheardLKnorrMEffertRWessingAHargreavesRJRetinal plasma extravasation in animals but not in humans: implications for the pathophysiology of migraine.
Brain1998;
121:
1231–7.
